BioAge Labs

Public

Vallejo, CaliforniaBusiness Products and Services (B2B)https://bioagelabs.com/

Last Round

Private Placement

Sep 27, 2024

Total Funding Raised

$502.5M

Company Overview

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company founded in 2015 that develops therapeutics for metabolic diseases by targeting the biology of human aging. The company utilizes a proprietary data-driven discovery platform that analyzes human aging data to identify novel drug targets. Its pipeline includes oral small-molecule inhibitors and agonists for conditions such as obesity. After being venture-backed by investors including Andreessen Horowitz and Sofinnova Investments, the company is now publicly traded on the NASDAQ (BIOA).

Sector

Business Products and Services (B2B)

AI Layer

Infrastructure

Keywords

computational drug discovery platform for aginghuman aging-focused drug discoveryAI-powered drug target identificationtherapeutics for metabolic diseasesobesity drug developmentoral NLRP3 inhibitor for obesitylongitudinal human biobank data analysisbiopharmaceutical R&D partnershipsclinical-stage biopharmaceutical companyAPJ agonists for obesityexercise-mimetic therapieshealthspan-targeting therapeutics

BioAge Labs Comps

Public and private peers based on sector, stage, and business model.

BioAge Labs comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioAge Labs Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Sep 27, 2024
IPO Announced	Sep 25, 2024
Series D	Feb 13, 2024
Series C	Dec 3, 2020
Series B	Jan 24, 2019
Series A	Jul 28, 2017

View all Funding Rounds

BioAge Labs Investors

Notable investors and investment history

BioAge Labs investors
Investor	Rounds
Andreessen Horowitz	Series B, IPO, Series D, Series C
Jefferies	IPO
Longitude Capital	Series D
RA Capital Management	IPO, Series D
SV Health Investors	Series D
AARP	Series C
Lilly Ventures	Series D

View all Investors

BioAge Labs Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BioAge Labs Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersVallejo, California

Employee Range96

Year Founded2015

Last FundingSep 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.